| 000 | 00867cas a2200289 a 4500 | ||
|---|---|---|---|
| 003 | KE-MeUCS | ||
| 005 | 20151209151414.0 | ||
| 008 | 060105c20029999wauar 0 a0eng | ||
| 020 | _a1574391623 | ||
| 022 | 0 |
_a1931-146X _21 |
|
| 040 |
_aDLC _cDLC _dDLC _dNSDP _dOCoLC _dOCLCF _dOCLCO _dOCoLC |
||
| 050 | 0 | 0 | _aRM302.H3 2003. |
| 100 | _a Hansten Philip D. | ||
| 245 | 0 | 0 |
_aManaging clinically important drug interactions. _cPhilip D. Hansten and John R. Horn. |
| 260 |
_aVancouver, WA : _bFacts & Comparisons, _c2003. |
||
| 300 |
_axiii, 661 p ; _c23 cm. |
||
| 500 | _aIncludes index. | ||
| 650 | 0 | _aDrug interactions | |
| 650 | 0 |
_aDrugs _94554 |
|
| 650 | 0 |
_aDrugs _94554 |
|
| 650 | 2 | _aDrug Interactions | |
| 650 | 7 | _aDrug interactions. | |
| 650 | 7 |
_aDrugs. _94554 |
|
| 650 | 7 |
_aDrugs _94554 |
|
| 710 | 2 | _aFacts and Comparisons (Firm) | |
| 942 |
_2lcc _cBK _tEMO |
||
| 999 |
_c83888 _d83887 |
||